Abstract
This study aimed to evaluate the safety and efficacy of multiple cycles of Lu-177-DOTA-Evans blue (EB)-TATE peptide receptor radionuclide therapy (PRR......
小提示:本篇文献需要登录阅读全文,点击跳转登录